What: Impact China II: Pharmaceutical R&D Global Summit
When: May 21 to 24, 2006
Where: Shangri-La Hotel - Beijing, China
The growing impact that China is having on the global pharmaceutical marketplace is currently being felt by the industry on a wide scale in areas such as outsourcing, clinical trials, manufacturing and more recently, drug discovery and development. But what should the industry realistically expect from their investments in China in the coming years?
Participated by more than 75 speakers, the summit will address the following issues:
- A Comparison of China vs. India, Japan, Asia-Pacific
- Intellectual Property & Patent Protection/Enforcement
- Venture Capital Investment, Technology Valuation/Transfer, East/West M&A's
- The Emerging Drug Discovery Landscape in China
- Outsourcing Preclinical & Clinical R&D to China
- Manufacturing, APIs and Generics in China
- Regulatory Insights in Clinical Trials, GMPs and Drugs/Biologics
- Business Practices, Commercialization and Marketing Strategies in the Chinese Market
- East/West Partnerships, Licensing, and Business Development Strategies
For the agenda, registration and other information, click here.
.jpg)
Comment Preview